NF-κB protects human papillomavirus type 38 E6/E7-immortalized human keratinocytes against tumor necrosis factor alpha and UV-mediated apoptosis

Journal of Virology

Volumn 85, Issue 17, 2011, Pages 9013-9022

  Hussain, Ishraq ^a,b   Fathallah, Ikbal ^a   Accardi, Rosita ^a   Yue, Jiping ^a   Saidj, Djamel ^a   Shukla, Ruchi ^a,d   Hasan, Uzma ^a,d   Gheit, Tarik ^a   Niu, Yamei ^a,c   Tommasino, Massimo ^a   Sylla, Bakary S ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b SHER E KASHMIR UNIVERSITY OF AGRICULTURAL SCIENCES AND TECHNOLOGY OF KASHMIR   (India)

^c Chinese Academy of Sciences and China National Center for Bioinformation   (China)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN E6; PROTEIN E7; PROTEIN P100; PROTEIN P52; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA; X LINKED INHIBITOR OF APOPTOSIS; ONCOPROTEIN;

APOPTOSIS; ARTICLE; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 38; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS; ULTRAVIOLET B RADIATION; WART VIRUS; CELL LINE; DRUG EFFECT; METABOLISM; PAPILLOMA VIRUS; PATHOGENICITY; RADIATION EXPOSURE;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 38;

APOPTOSIS; CELL LINE; CELL SURVIVAL; HUMANS; KERATINOCYTES; NF-KAPPA B; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80052286626     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00002-11     Document Type: Article

References (57)

1. Accardi, R., et al. 2006. Skin human papillomavirus type 38 alters p5. functions by accumulation of deltaNp73. EMBO Rep. 7:334-340.
2. Accardi, R., et al. 2011. I{kappa}B kinase {beta} promotes cell survival by antagonizing p53 functions through {Delta}Np73{alpha} phosphorylation and stabilization. Mol. Cell, Biol. 31:2210-2226.
3. An, J., et al. 2008. Inactivation of the CYLD deubiquitinase by HPV E6 mediates hypoxia-induced NF-kappaB activation. Cancer Cell 14:394-407.
4. Basile, J. R., V. Zacny, and K. Munger. 2001. The cytokines tumor necrosis factor-alpha (TNF-alpha) and TNF-related apoptosis-inducing ligand differentially modulate proliferation and apoptotic pathways in human keratinocytes expressing the human papillomavirus-16 E7 oncoprotein. J. Biol. Chem. 276:22522-22528.
5. Boccardo, E., F. Noya, T. R. Broker, L. T. Chow, and L. L. Villa. 2004. HPV-18 confers resistance to TNF-alpha in organotypic cultures of human keratinocytes. Virology 328:233-243.
6. Bouvard, V., A.-S. Gabet, R. Accardi, B. S. Sylla, and M. Tommasino. 2006. The cutaneous human papillomavirus types and non-melanoma skin cancer, p. 369-377. In S. Campo (ed.), Papillomavirus research: from natural history to vaccines and beyond. Caister Academic Press, Norfolk, United Kingdom.
7. Brown, K., S. Gerstberger, L. Carlson, G. Franzoso, and U. Siebenlist. 1995. Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 267:1485-1488.
8. Cahir-McFarland, E. D., et al. 2004. Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells. J. Virol. 78:4108-4119.
9. Cahir-McFarland, E. D., D. M. Davidson, S. L. Schauer, J. Duong, and E. Kieff. 2000. NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells. Proc. Natl. Acad. Sci. U. S. A. 97:6055-6060.
10. Caldeira, S., et al. 2003. The E6 and E7 proteins of the cutaneous human papillomavirus type 38 display transforming properties. J. Virol. 77:2195-2206.
11. Chaturvedi, V., et al. 1999. Apoptosis in proliferating, senescent, and immortalized keratinocytes. J. Biol. Chem. 274:23358-23367.
12. Claudio, E., K. Brown, S. Park, H. Wang, and U. Siebenlist. 2002. BAFFinduced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat. Immunol. 3:958-965.
13. Coope, H. J., et al. 2002. CD40 regulates the processing of NF-kappaB2 p10. to p52. EMBO J. 21:5375-5385.
14. Dejardin, E., et al. 2002. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity 17:525-535.
15. Descargues, P., A. K. Sil, and M. Karin. 2008. IKKalpha, a critical regulator of epidermal differentiation and a suppressor of skin cancer. EMBO J. 27:2639-2647.
16. de Villiers, E. M., C. Fauquet, T. R. Broker, H. U. Bernard, and H. zur Hausen. 2004. Classification of papillomaviruses. Virology 324:17-27.
17. Dong, W., et al. 2005. Skin hyperproliferation and susceptibility to chemical carcinogenesis in transgenic mice expressing E6 and E7 of human papillomavirus type 38. J. Virol. 79:14899-14908.
18. Dong, Z., et al. 1999. Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferonbeta. Cancer Res. 59:872-879.
19. Duffey, D. C., et al. 1999. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo. Cancer Res. 59:3468-3474.
20. Filippova, M., T. A. Brown-Bryan, C. A. Casiano, and P. J. Duerksen-Hughes. 2005. The human papillomavirus 16 E6 protein can either protect or further sensitize cells to TNF: effect of dose. Cell Death Differ. 12:1622-1635.
21. Gabet, A. S., et al. 2008. Impairment of the telomere/telomerase system and genomic instability are associated with keratinocyte immortalization induced by the skin human papillomavirus type 38. FASEB J. 22:622-632.
22. Gaur, U., and B. B. Aggarwal. 2003. Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem. Pharmacol. 66:1403-1408.
23. Guasparri, I., S. A. Keller, and E. Cesarman. 2004. KSHV vFLIP is essential for the survival of infected lymphoma cells. J. Exp. Med. 199:993-1003.
24. Hasegawa, T., et al. 2003. Expression of the inhibitor of apoptosis (IAP) family members in human neutrophils: up-regulation of cIAP2 by granulocyte colony-stimulating factor and overexpression of cIAP2 in chronic neutrophilic leukemia. Blood 101:1164-1171.
25. Havard, L., P. Delvenne, P. Frare, J. Boniver, and S. L. Giannini. 2002. Differential production of cytokines and activation of NF-kappaB in HPVtransformed keratinocytes. Virology 298:271-285.
26. Havard, L., S. Rahmouni, J. Boniver, and P. Delvenne. 2005. High levels of p105 (NFKB1) and p100 (NFKB2) proteins in HPV16-transformed keratinocytes: role of E6 and E7 oncoproteins. Virology 331:357-366.
27. Hayden, M. S., and S. Ghosh. 2008. Shared principles in NF-kappaB signaling. Cell 132:344-362.
28. James, M. A., J. H. Lee, and A. J. Klingelhutz. 2006. Human papillomavirus type 16 E6 activates NF-kappaB, induces cIAP-2 expression, and protects against apoptosis in a PDZ binding motif-dependent manner. J. Virol. 80:5301-5307.
29. Karin, M. 2006. Nuclear factor-kappaB in cancer development and progression. Nature 441:431-436.
30. Kato, T., Jr., M. Delhase, A. Hoffmann, and M. Karin. 2003. CK2 Is a C-terminal IkappaB kinase responsible for NF-kappaB activation during the UV response. Mol. Cell 12:829-839.
31. Kfoury, Y., R. Nasr, O. Hermine, H. de The, and A. Bazarbachi. 2005. Proapoptotic regimes for HTLV-I-transformed cells: targeting Tax and the NF-kappaB pathway. Cell Death Differ. 12(Suppl. 1):871-877.
32. Li, J. J., J. S. Rhim, R. Schlegel, K. H. Vousden, and N. H. Colburn. 1998. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes. Oncogene 16:2711-2721.
33. Liu, B., et al. 2006. A critical role for I kappaB kinase alpha in the development of human and mouse squamous cell carcinomas. Proc. Natl. Acad. Sci. U. S. A. 103:17202-17207.
34. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408.
35. Loercher, A., et al. 2004. Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma. Cancer Res. 64:6511-6523.
36. Luftig, M., et al. 2004. Epstein-Barr virus latent infection membrane protei 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NFkappaB activation. Proc. Natl. Acad. Sci. U. S. A. 101:141-146.
37. Mantovani, F., and L. Banks. 2001. The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 20:7874-7887.
38. Massimi, P., et al. 2008. Comparative transforming potential of different human papillomaviruses associated with non-melanoma skin cancer. Virology 371:374-379.
39. Mayo, M. W., et al. 1997. Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science 278:1812-1815.
40. Michel, A., A. Kopp-Schneider, H. Zentgraf, A. D. Gruber, and E. M. de Villiers. 2006. E6/E7 expression of human papillomavirus type 20 (HPV-20. and HPV-27 influences proliferation and differentiation of the skin in UVirradiated SKH-hr1 transgenic mice. J. Virol. 80:11153-11164.
41. Münger, K., et al. 2004. Mechanisms of human papillomavirus-induced oncogenesis. J. Virol. 78:11451-11460.
42. Münger, K., et al. 2001. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 20:7888-7898.
43. Muñoz, N., et al. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348:518-527.
44. Nees, M., et al. 2001. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes. J. Virol. 75:4283-4296.
45. Niu, Y., et al. 2006. A nuclear export signal and phosphorylation regulate Dok1 subcellular localization and functions. Mol. Cell. Biol. 26:4288-4301.
46. Park, E., et al. 2007. Reduction in IkappaB kinase alpha expression promotes the development of skin papillomas and carcinomas. Cancer Res. 67:9158-9168.
47. Pfister, H. 2003. Human papillomavirus and skin cancer. J. Natl. Cancer Inst. Monogr. 31:5.
48. Schaper, I. D., et al. 2005. Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8. Cancer Res. 65:1394-1400.
49. Sylla, B. S., et al. 1998. Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta. Proc. Natl. Acad. Sci. U. S. A. 95:10106-10111.
50. Trompouki, E., et al. 2003. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature 424:793-796.
51. Underbrink, M. P., H. L. Howie, K. M. Bedard, J. I. Koop, and D. A. Galloway. 2008. E6 proteins from multiple human betapapillomavirus types degrade Bak and protect keratinocytes from apoptosis after UVB irradiation. J. Virol. 82:10408-10417.
52. van Hogerlinden, M., B. L. Rozell, L. Ahrlund-Richter, and R. Toftgard. 1999. Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling. Cancer Res. 59:3299-3303.
53. Van Waes, C., M. Yu, L. Nottingham, and M. Karin. 2007. Inhibitor-kappaB kinase in tumor promotion and suppression during progression of squamous cell carcinoma. Clin. Cancer Res. 13:4956-4959.
54. Wang, C. Y., M. W. Mayo, R. G. Korneluk, D. V. Goeddel, and A. S. Baldwin, Jr. 1998. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281:1680-1683.
55. Wu, Z. H., Y. Shi, R. S. Tibbetts, and S. Miyamoto. 2006. Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli. Science 311:1141-1146.
56. Yuan, H., et al. 2005. Human papillomavirus type 16 E6 and E7 oncoproteins upregulate c-IAP2 gene expression and confer resistance to apoptosis. Oncogene 24:5069-5078.
57. Zhu, F., et al. 2009. Critical role of IkappaB kinase alpha in embryonic skin development and skin carcinogenesis. Histol. Histopathol. 24:265-271.